Short on time? These are the highlights or our latest Bulletin or if you have a moment read more below.
Tim Watson, Director
From frameworks to foresight: the economics of healthcare innovation
New life-saving treatments are on the horizon but they often challenge current payment frameworks: the US’ ‘Most Favoured Nation’ policy – and developments in the UK in response - make it clear that how to pay for healthcare is an increasingly pressing question.
Similarly, we also looked at the potential of long-acting therapies to enhance patient outcomes and alleviate the strain on healthcare systems – our research makes the case for HTA frameworks to reflect the comprehensive benefits of these therapies to enable patient access and to incentivise innovation in this area.
And to end on a celebratory note, we’d like to congratulate Adrian Towse, Emeritus Director and Visiting Senior Research Fellow at OHE, who has received the Avedis Donabedian Outcomes Research Lifetime Achievement Award from ISPOR. Adrian led OHE for over 25 years. His work has influenced health policy and economic thinking both at OHE and worldwide. We are delighted to be able to celebrate with him.
The case for a UK system-shift in cell and gene therapies
The value of cell and gene therapies to the UK economy
Our latest research shows improving access to cell and gene therapies (CGTs) across four key indications could generate over £20 billion in value over 10 years. Benefits include improved patient health, reduced NHS costs, and gains for the wider UK economy. The analysis highlights the potential of a coordinated CGT system-shift and the importance of strategic investment in infrastructure, workforce, and research.
Rethinking how health systems assess long-acting therapies
Understanding the Full Value of Long-Acting Therapies: less is more?
Long-acting therapies can improve outcomes for patients and ease pressure on health systems, but their broader benefits like productivity, patient choice, and environmental impact can be undervalued in HTA decisions. Adapting value frameworks to recognise these wider impacts could unlock innovation, support sustainable investment, and deliver better long-term outcomes.
The missing link in the NHS 10 Year Health Plan: climate and health
Environmental sustainability in the NHS 10 Year Health Plan: The need for green
The NHS 10 Year Health Plan sets out goals for improving care and inequalities, but it doesn’t go far enough on climate action. Making sustainability central to health strategy is important for protecting both people and the planet.
The OHE MSc Fellowship covers full tuition and provides a monthly stipend. Fellows work part-time at OHE while completing their MSc at City St George’s or UCL, gaining practical experience in applied health economics. The programme offers a route to develop research skills and a career at OHE.
